Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$712K Hold
3,207
0.38% 61
2023
Q1
$775K Hold
3,207
0.43% 54
2022
Q4
$856K Hold
3,207
0.57% 38
2022
Q3
$723K Hold
3,207
0.45% 48
2022
Q2
$780K Hold
3,207
0.47% 46
2022
Q1
$776K Sell
3,207
-152
-5% -$34.9K 0.4% 53
2021
Q4
$768K Buy
3,359
+80
+2% +$16.9K 0.41% 54
2021
Q3
$697K Hold
3,279
0.39% 55
2021
Q2
$799K Buy
3,279
+80
+3% +$19.7K 0.46% 50
2021
Q1
$797K Buy
3,199
+60
+2% +$14.3K 0.48% 46
2020
Q4
$735K Sell
3,139
-120
-4% -$27.7K 0.51% 49
2020
Q3
$834K Hold
3,259
0.67% 40
2020
Q2
$812K Buy
3,259
+95
+3% +$21.7K 0.73% 34
2020
Q1
$718K Hold
3,164
0.74% 35
2019
Q4
$724K Buy
+3,164
New +$697K 0.6% 43

Other funds holding AMGN

Heron Financial Group's AMGN Position: Q2 2023 in Review

Heron Financial Group held its Amgen (AMGN) position steady in Q2 2023 at 3,207 shares worth $712K. The position accounts for 0.38% of the portfolio, ranked #61.

Heron Financial Group first reported a position in AMGN in Q4 2019 and has held it in 15 quarters since. The position peaked at $856K in Q4 2022. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • Heron Financial Group held 3,207 shares of Amgen worth $712K as of Q2 2023.
  • Heron Financial Group left its Amgen share count unchanged in Q2 2023.
  • Amgen made up 0.38% of Heron Financial Group's portfolio in Q2 2023, its #61 holding.
  • Heron Financial Group first reported a position in Amgen in Q4 2019 and has held it in 15 quarters since.
  • Heron Financial Group's Amgen position peaked at $856K in Q4 2022.
  • 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Heron Financial Group's 13F filing for Q2 2023, filed 10 Aug 2023.